TKL Named a Top CRO
Working in this competitive landscape, filled with mergers and very large CROs, it is an honor to be recognized by Pharma Tech Outlook as a Top CRO. TKL Research was founded over 75 years ago and has since weathered many storms. We always strive to be the best, the most knowledgeable, the most efficient and flexible in order to offer our sponsors the best service and results possible.
Our experience is indisputable and our record speaks for itself. We have an expertise in dermatology, run our own 40-bed pharmacology unit out of our NJ headquarters and offer 4 outpatient clinics in the NY/NJ metro area. We will run your phase I study under the supervision of our skilled team and will complete phases II-IV with this same team in place. Our full service CRO capabilities allow us to approach each and every study with an all hands on deck approach.
We are running all studies smoothly and safely. In light of the pandemic, we are in the process of moving all applicable CRO services to online/mobile platforms – virtual screening and evaluations, direct data capture and detailed risk mitigation plans in the case of a 2nd wave of COVID-19. We will continue to complete our studies successfully in this new normal.
Running studies phases I-IV. We’re not your average CRO.
Sorry, the comment form is closed at this time.